Treeline Biosciences has filed a notice of an exempt offering of securities to raise $421,779,808.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Treeline Biosciences is raising up to $421,779,808.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Joshua Bilenker played a…